Seattle Genetics investors retreat on robust Adcetris pricing
23 August 2011
Donna Young
Please Login to read the full article.
23 August 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Early Adcetris OK no surprise to SGEN after taking US FDA's advice
- Black-box warning imposed on Seattle Genetics' new lymphoma drug
- FDA's Pazdur urges Seattle Genetics to connect quickly with agency post-positive ODAC
- Dendreon rockets on unexpected high growth 4Q Provenge sales
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
